What We Do

Unlock more of your clinical value with Transpire Bio's inhalation technologies

We partner with leading pharmaceutical companies who are looking to accelerate innovation and unlock clinical value by leveraging the power of inhaled therapeutics. 

Unlock more of your clinical value with Transpire Bio's inhalation technologies

We partner with leading pharmaceutical companies who are looking to accelerate innovation and unlock clinical value by leveraging the power of inhaled therapeutics. 

Inhaled therapeutics have the potential to help: 

Gain insight into our expertise

Gain insight into our expertise

Multiple partnership opportunities 

We offer multiple partnership avenues at different points in the development roadmap:

Co-development partnerships –
Partner therapies

Strategic partnerships to develop innovative therapies by applying Transpire Bio’s inhalation technology platforms to a pharmaceutical partner’s existing novel or in-market therapeutics. 

Co-Development partnerships –
Transpire Bio therapies

Strategic partnerships and licensing agreements to bring Transpire Bio’s early-stage and mid-stage therapeutic assets to market by leveraging a pharmaceutical partner’s late-stage clinical, regulatory, and commercialization capabilities. 

Commercialization partnerships –
Complex generics

Licensing agreements for the commercialization of one of Transpire Bio’s early-entry, difficult-to-replicate asthma/COPD generic inhaled therapies. 

Let’s discuss how Transpire Bio can partner with you to advance inhaled therapeutics

Let’s discuss how Transpire Bio can partner with you to advance inhaled therapeutics